Error: Could not add to watchlist. X

AXA Framlington Biotech Fund

+ Watchlist
FRABIOZ:LN
328.20
GBp
8.40
2.63%
As of 00:59:30 ET on 07/01/2015.
Volume
0
Previous Close
319.80
52Wk Range
191.44 - 341.70
1 Yr Return
61.15%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/01/2015)
328.2
Total Assets (m GBp) (on 06/30/2015)
732.005
Inception Date
04/16/2012
Last Dividend (on 03/02/2015)
-
Dividend Indicated Gross Yield
-
Fund Managers
LINDEN THOMSON
Front Load Fee
0.00%
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
0.75%
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 987.09 k 72.31 m 9.60
Biogen Inc 240.48 k 62.52 m 8.30
Celgene Corp 773.91 k 58.00 m 7.70
Amgen Inc 522.62 k 53.48 m 7.10
Illumina Inc 273.49 k 36.91 m 4.90
Alexion Pharmaceuticals Inc 329.96 k 35.40 m 4.70
Vertex Pharmaceuticals Inc 394.49 k 33.14 m 4.40
Regeneron Pharmaceuticals Inc 94.25 k 31.63 m 4.20
Incyte Corp 365.48 k 26.36 m 3.50
BioMarin Pharmaceutical Inc 320.60 k 26.36 m 3.50
Profile
AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.
ADDRESS
AXA Framlington Unit Management Ltd
7 Newgate Street
London EC1A 7NX
United Kingdom
PHONE
44-207-374-4100